RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 HPS2-THRIVE: Niacin Fails to Show Benefit in Patients at High Risk of Vascular Events
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 2
SP 13
OP 14
DO 10.1177/155989771302005
UL http://mdc.sagepub.com/content/13/2/13.abstract
AB The results of this large randomized controlled trial in patients with well-controlled lipid levels but who are at a high risk of cardiovascular events once again call into question the the clinical benefits of niacin despite an increase in high-density lipoprotein cholesterol (HDL-C), and reductions in triglyceride levels and low density lipoprotein cholesterol levels. This article presents the results of the Treatment of HDL to Reduce the Incidence of Vascular Events trial [HPS2-THRIVE Collaborative Group. Eur Heart J 2013].